How many studies have been conducted on Carbonic Anhydrase Ix?

BiohacksAI has indexed 300 PubMed studies on Carbonic Anhydrase Ix, including 2 randomized controlled trials (RCTs). 27% of studies involve human subjects.

What are the main research areas for Carbonic Anhydrase Ix?

The primary research domains for Carbonic Anhydrase Ix are 🔬 Oncology, 🫘 Kidney, ⏳ Longevity & Aging. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

Carbonic Anhydrase Ix

A carbonic anhydrase and transmembrane protein that consists of an N-terminal PROTEOGLYCAN-like domain, a catalytic region, a single-pass transmembrane domain, and a short intracellular tail. It functions as a dimer and is expressed primarily by cells of the GASTROINTESTINAL TRACT; BILE DUCT EPITHELIUM; and GALL BLADDER. It is expressed at high levels in many solid tumors, especially CLEAR CELL RENAL CARCINOMA, in response to CELL HYPOXIA.

300+ PubMed studies analyzed · 2 RCTs · Evidence Score: 43.7

Research Domains

Carbonic Anhydrase Ix has been studied across 11 research domains including 🔬 Oncology, 🫘 Kidney, ⏳ Longevity & Aging, 🧠 Focus & Attention, 🫁 Liver & Detox. The primary research focus is 🔬 Oncology with 87% of studies addressing this area.

Loading evidence profile...

This evidence profile for Carbonic Anhydrase Ix is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.